Kylie Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kylie Yang has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Cally Jo Elizabeth Haynes
University College London
6 shared publications - Jennifer Ruth Hiscock
University of Kent, Canterbury, CT2 7NH, UK
4 shared publications - Charlotte K. Hind
UK Health Security Agency
3 shared publications Kira L. F. Hilton
University of Kent, Canterbury, CT2 7NH, UK
3 shared publications- Precious I. A. Popoola
School of Chemistry and Forensic Science, University of Kent, Canterbury, CT2 7NH, UK
3 shared publications Alvaro Keskküla
Chemistry Department, UCL, 20 Gordon Street, London WC1H 0AJ, UK
2 shared publications
Latest Publications
- Open Access
- 10 March 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (17) , 8567-8579
Amino acid appended supramolecular self-associating amphiphiles demonstrate dual activity against both MRSA and ovarian cancer
Novel amphiphiles target cell membranes, demonstrating biological efficacy against resistant S. aureus and ovarian cancer, with strong mechanistic and DMPK evidence for future therapeutic development.
- 10 March 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (17) , 8567-8579
Open AccessAmino acid appended supramolecular self-associating amphiphiles demonstrate dual activity against both MRSA and ovarian cancer
Novel amphiphiles target cell membranes, demonstrating biological efficacy against resistant S. aureus and ovarian cancer, with strong mechanistic and DMPK evidence for future therapeutic development.
- Open Access
- 3 March 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (17) , 8580-8594
An increased throughput workflow to identify ion transport and membrane lysis agents for antimicrobial discovery
Small molecule ion transporters have shown promise as potential therapeutics for microbial infections, cancer and channelopathies. However, there are still gaps in our understanding of how ion transport function in model vesicle membranes translates to cell membranes of interest. The lipid composition of the membranes of bacterial and cancer cells differs markedly from normal human cells, yet the influence of the lipid composition on membrane function is rarely investigated – in part because of the low throughput and high cost of ion transport experiments. Here, we report an increased throughput Workflow to identify biologically relevant, pH-driven ion transport and membrane lysis pathways in vesicle membranes. We developed a set of four assays designed to report on different transport and lysis processes. We validated our assays against a panel of known transporters and produced a stepwise Workflow for the evaluation of libraries of compounds. We applied our Workflow to screen a library (Library 1) of 31 supramolecular, self-associating amphiphiles (SSAs) for transport and lysis activity in a range of vesicles with different lipid compositions, designed to mimic different types of cells, and consequently identified seven promising transporters. Antimicrobial experiments found that six of these promising transporters showed good antimicrobial activity against clinically relevant Staphylococcus aureus strains, highlighting the promise of our Workflow in identifying potential antimicrobial agents. We then applied our Workflow to investigate the ion transport and lysis properties of a second library (Library 2) of SSAs with established antimicrobial and anticancer properties, aiming to provide insight into the biological modes of action.
- 3 March 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (17) , 8580-8594
Open AccessAn increased throughput workflow to identify ion transport and membrane lysis agents for antimicrobial discovery
Small molecule ion transporters have shown promise as potential therapeutics for microbial infections, cancer and channelopathies. However, there are still gaps in our understanding of how ion transport function in model vesicle membranes translates to cell membranes of interest. The lipid composition of the membranes of bacterial and cancer cells differs markedly from normal human cells, yet the influence of the lipid composition on membrane function is rarely investigated – in part because of the low throughput and high cost of ion transport experiments. Here, we report an increased throughput Workflow to identify biologically relevant, pH-driven ion transport and membrane lysis pathways in vesicle membranes. We developed a set of four assays designed to report on different transport and lysis processes. We validated our assays against a panel of known transporters and produced a stepwise Workflow for the evaluation of libraries of compounds. We applied our Workflow to screen a library (Library 1) of 31 supramolecular, self-associating amphiphiles (SSAs) for transport and lysis activity in a range of vesicles with different lipid compositions, designed to mimic different types of cells, and consequently identified seven promising transporters. Antimicrobial experiments found that six of these promising transporters showed good antimicrobial activity against clinically relevant Staphylococcus aureus strains, highlighting the promise of our Workflow in identifying potential antimicrobial agents. We then applied our Workflow to investigate the ion transport and lysis properties of a second library (Library 2) of SSAs with established antimicrobial and anticancer properties, aiming to provide insight into the biological modes of action.
- Open Access
- 5 March 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Amino acid appended supramolecular self-associating amphiphiles demonstrate dual activity against both MRSA and ovarian cancer
Differences in the lipid composition of prokaryotic and eukaryotic cell membranes are well understood and can be exploited to produce novel antimicrobials. However, what is less well recognised is that alteration in the phospholipid composition of the cell membrane is also one of the first phenotypic changes when a cell becomes cancerous. In addition, changes in phospholipid cell membrane composition are a known cause of drug resistance in both microbial disease and cancer. Here we present a series of chiral, amino acid appended supramolecular self-associating amphiphiles that suggest membrane active technologies can be used to simultaneously produce novel drugs in the fight against two of the greatest global health threats facing us today, antimicrobial resistant infections and cancer diseases. We demonstrate the antimicrobial and anticancer efficacy of this membrane active amphiphile technology against susceptible and resistant Staphylococcus aureus and ovarian cancer cells. We hypothesise a mode of action, building on a previous body of evidence, through a combination of vesicle, NMR spectroscopy and patch clamp experiments. We also provide evidence that supports the potential for this class of compound to be developed as pharmaceutical agents against these diseases through in vitro drug metabolism and pharmacokinetics experiments alongside in vivo Galleria mellonella toxicity experiments.
- 5 March 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessAmino acid appended supramolecular self-associating amphiphiles demonstrate dual activity against both MRSA and ovarian cancer
Differences in the lipid composition of prokaryotic and eukaryotic cell membranes are well understood and can be exploited to produce novel antimicrobials. However, what is less well recognised is that alteration in the phospholipid composition of the cell membrane is also one of the first phenotypic changes when a cell becomes cancerous. In addition, changes in phospholipid cell membrane composition are a known cause of drug resistance in both microbial disease and cancer. Here we present a series of chiral, amino acid appended supramolecular self-associating amphiphiles that suggest membrane active technologies can be used to simultaneously produce novel drugs in the fight against two of the greatest global health threats facing us today, antimicrobial resistant infections and cancer diseases. We demonstrate the antimicrobial and anticancer efficacy of this membrane active amphiphile technology against susceptible and resistant Staphylococcus aureus and ovarian cancer cells. We hypothesise a mode of action, building on a previous body of evidence, through a combination of vesicle, NMR spectroscopy and patch clamp experiments. We also provide evidence that supports the potential for this class of compound to be developed as pharmaceutical agents against these diseases through in vitro drug metabolism and pharmacokinetics experiments alongside in vivo Galleria mellonella toxicity experiments.
- Open Access
- 3 February 2025
- Published by Wiley in Chemistry–Methods
- Vol. 5 (8)
High‐Throughput and Automated Anion Transport Assays
Ion transport across biological lipid membranes is crucial for both health and disease, prompting investigation into synthetic ion transporters as potential therapeutics. However, state of the art methods for assessing transporter activity are often time‐consuming and resource‐intensive, hindering the screening of large compound libraries. In this work we have developed an automated high‐throughput assay capable of determining 24 EC50 values in a single day. This assay, adapted from the established lucigenin Cl−/NO3− antiport method, has been optimised for multi‐well plates with fully automated liquid handling. Notably, our protocol allows for the use of DMSO as a delivery solvent for target molecules, enhancing its versatility. Validation with six standard ion transporters demonstrated a strong correlation between the EC50 values obtained through our assay and previously reported values, confirming its efficacy and potential for broader applications in the field of ion transport.
- 3 February 2025
- Published by Wiley in Chemistry–Methods
- Vol. 5 (8)
Open AccessHigh‐Throughput and Automated Anion Transport Assays
Ion transport across biological lipid membranes is crucial for both health and disease, prompting investigation into synthetic ion transporters as potential therapeutics. However, state of the art methods for assessing transporter activity are often time‐consuming and resource‐intensive, hindering the screening of large compound libraries. In this work we have developed an automated high‐throughput assay capable of determining 24 EC50 values in a single day. This assay, adapted from the established lucigenin Cl−/NO3− antiport method, has been optimised for multi‐well plates with fully automated liquid handling. Notably, our protocol allows for the use of DMSO as a delivery solvent for target molecules, enhancing its versatility. Validation with six standard ion transporters demonstrated a strong correlation between the EC50 values obtained through our assay and previously reported values, confirming its efficacy and potential for broader applications in the field of ion transport.
- Open Access
- 30 October 2024
- Published by American Chemical Society (ACS) in ChemRxiv
High-throughput and Automated Anion Transport Assays
Ion transport across biological lipid membranes is crucial for both health and disease, prompting investigation into synthetic ion transporters as potential therapeutics. However, state of the art methods for assessing transporter activity are often time-consuming and resource-intensive, hindering the screening of large compound libraries. In this work we have developed an automated high-throughput assay capable of determining 24 EC50 values in a single day. This assay, adapted from the established lucigenin Cl-/NO3- antiport method, has been optimised for multi-well plates with fully automated liquid handling. Notably, our protocol allows for the use of DMSO as a delivery solvent for target molecules, enhancing its versatility. Validation with six standard ion transporters demonstrated a strong correlation between the EC50 values obtained through our assay and previously reported values, confirming its efficacy and potential for broader applications in the field of ion transport.
- 30 October 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessHigh-throughput and Automated Anion Transport Assays
Ion transport across biological lipid membranes is crucial for both health and disease, prompting investigation into synthetic ion transporters as potential therapeutics. However, state of the art methods for assessing transporter activity are often time-consuming and resource-intensive, hindering the screening of large compound libraries. In this work we have developed an automated high-throughput assay capable of determining 24 EC50 values in a single day. This assay, adapted from the established lucigenin Cl-/NO3- antiport method, has been optimised for multi-well plates with fully automated liquid handling. Notably, our protocol allows for the use of DMSO as a delivery solvent for target molecules, enhancing its versatility. Validation with six standard ion transporters demonstrated a strong correlation between the EC50 values obtained through our assay and previously reported values, confirming its efficacy and potential for broader applications in the field of ion transport.
- Open Access
- 29 September 2022
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 12 (43) , 27877-27880
A water-soluble membrane transporter for biologically relevant cations
Synthetic ionophores are promising therapeutic targets, yet poor water solubility limits their potential for translation into the clinic. Here we report a water soluble, supramolecular self-associating amphiphile (SSA) with cation transport function.
- 29 September 2022
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 12 (43) , 27877-27880
Open AccessA water-soluble membrane transporter for biologically relevant cations
Synthetic ionophores are promising therapeutic targets, yet poor water solubility limits their potential for translation into the clinic. Here we report a water soluble, supramolecular self-associating amphiphile (SSA) with cation transport function.
- 13 September 2021
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 19 (43) , 9339-9357
Strategies for organelle targeting of fluorescent probes
Here we provide a comprehensive review of methods for targeting fluorescent cargo to sub-cellular organelles.
- 13 September 2021
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 19 (43) , 9339-9357
Strategies for organelle targeting of fluorescent probes
Here we provide a comprehensive review of methods for targeting fluorescent cargo to sub-cellular organelles.